Literature DB >> 744498

Renal clearance of pancreatic and salivary amylase relative to creatinine in patients with chronic renal insufficiency.

J B Keogh, K F McGeeney, M I Drury, T B Counihan, M D O'Donnell.   

Abstract

Pancreatic and salivary amylase/creatinine clearance ratios in patients with various degrees of renal impairment were compared with those obtained for control subjects. In chronic renal insufficiency (mean GFR 30 ml/min +/- 15 SD; n = 13) the clearance ratios for pancreatic (mean 3.5 +/- 1.85 SD) and salivary (mean 2.3 +/- 1.3 SD) amylase were significantly higher (P less than 0.05) than those in controls. Corresponding control values (n = 26) were 2.64 +/- 0.86 (pancreatic) and 1.64 +/- 0.95 (salivary). Three patients showed values above the normal limit. In the diabetic group (mean GFR 41 ml/min +/- 22 SD; n = 10) salivary amylase/creatinine clearance ratios (mean 2.36 +/- 1.55 SD) were significantly higher than in controls (P less than 0.05). Three patients showed raised values. Pancreatic amylase clearance was raised in only one of these patients. Three patients with terminal disease (mean GFR 10 ml/min) showed markedly raised (two- to threefold) clearance ratios for both salivary and pancreatic amylase. Of a total of 26 patients, eight had increased total amylase/creatinine clearance ratios. Pancreatic amylase/creatinine clearance was increased in seven patients, while nine patients showed raised salivary amylase/creatinine ratios. Patients with raised clearance ratios did not have clinical evidence of pancreatitis. We suggest that, in the presence of impaired renal function, a high amylase/creatinine clearance ratio need not be indicative of pancreatic disease.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 744498      PMCID: PMC1412317          DOI: 10.1136/gut.19.12.1125

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  23 in total

1.  Amylase clearance and excretion during water diuresis.

Authors:  R L MCGEACHIN; L A HARGAN
Journal:  Proc Soc Exp Biol Med       Date:  1957-06

2.  Renal clearance of amylase in man.

Authors:  L A HARGAN; R L MCGEACHIN
Journal:  J Appl Physiol       Date:  1956-07       Impact factor: 3.531

3.  A rapid, new method for quantitative analysis of human amylase isozymes.

Authors:  T Takeuchi; T Matsushima; T Sugimura; T Kozu; T Takeuchi
Journal:  Clin Chim Acta       Date:  1974-07-31       Impact factor: 3.786

4.  Hyperamylasemia with carcinoma of the lung.

Authors:  R W Ammann; J E Berk; L Fridhandler; M Ueda; W Wegmann
Journal:  Ann Intern Med       Date:  1973-04       Impact factor: 25.391

5.  Renal handling of amylase: evidence for reabsorption by stop-flow analysis.

Authors:  A Noda
Journal:  Metabolism       Date:  1972-04       Impact factor: 8.694

6.  Amylase-creatinine clearance ratio in pancreatitis.

Authors:  H K Dürr; J C Bode; P G Lankisch; H Koop
Journal:  N Engl J Med       Date:  1977-03-17       Impact factor: 91.245

7.  Pancreatic and salivary amylase/creatinine clearance ratios in normal subjects and in patients with chronic pancreatitis.

Authors:  J E Hegarty; M D O'Donnell; K F McGeeney; O Fitzgerald
Journal:  Gut       Date:  1978-05       Impact factor: 23.059

8.  Differential serum amylase determination by use of an inhibitor, and design of a routine procedure.

Authors:  M D O'Donnell; O FitzGerald; K F McGeeney
Journal:  Clin Chem       Date:  1977-03       Impact factor: 8.327

9.  Mechanism of increased renal clearnace of amylase/creatinine in acute pancreatitis.

Authors:  S G Johnson; C J Ellis; M D Levitt
Journal:  N Engl J Med       Date:  1976-11-25       Impact factor: 91.245

10.  Distribution, turnover, and mechanism of renal excretion of amylase in the baboon.

Authors:  W C Duane; R Frerichs; M D Levitt
Journal:  J Clin Invest       Date:  1971-01       Impact factor: 14.808

View more
  5 in total

1.  Sarcoidosis and the pancreas.

Authors:  P A McCormick; M O'Donnell; K McGeeney; O FitzGerald; D A McCormick; M X FitzGerald
Journal:  Ir J Med Sci       Date:  1988-06       Impact factor: 1.568

2.  Hyperamylasaemia following extracorporeal perfusion.

Authors:  F Given; K F McGeeney; M D O'Donnell
Journal:  Ir J Med Sci       Date:  1984-06       Impact factor: 1.568

3.  Pancreatic enzymes in chronic renal failure and transplant patients.

Authors:  G Montalto; A Carroccio; V Sparacino; D Lorello; D Di Martino; M Soresi; A Galione; A Notarbartolo
Journal:  Int J Pancreatol       Date:  1992-12

4.  Gastric and pancreatic functions in haemodialyzed patients.

Authors:  J Malyszko; S Sosnowski; M Mazerska; M Raimer; J Romatowski; J Stasiewicz; A Kemona; M Mysliwiec
Journal:  Int Urol Nephrol       Date:  1995       Impact factor: 2.370

5.  Independent association between low serum amylase and non-alcoholic fatty liver disease in asymptomatic adults: a cross-sectional observational study.

Authors:  Kei Nakajima; Haruki Oshida; Toshitaka Muneyuki; Masafumi Saito; Yumiko Hori; Hiroshi Fuchigami; Masafumi Kakei; Hiromi Munakata
Journal:  BMJ Open       Date:  2013-01-03       Impact factor: 2.692

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.